Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shares traded up 3.3% during trading on Friday . The stock traded as high as $303.95 and last traded at $303.25. Approximately 7,015,461 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 5,260,806 shares. The stock had previously closed at $293.56.
Analysts Set New Price Targets
Several analysts recently issued reports on the company. Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Needham & Company LLC boosted their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Citigroup restated a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Finally, Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $348.33.
Check Out Our Latest Analysis on ALAB
Astera Labs Trading Up 3.3%
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the company posted $0.44 EPS. Astera Labs’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Insider Activity at Astera Labs
In related news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 592,244 shares of company stock worth $209,729,973. 10.40% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Astera Labs
Several large investors have recently made changes to their positions in the business. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs in the 2nd quarter valued at $25,000. Archer Investment Corp bought a new position in shares of Astera Labs during the 2nd quarter worth approximately $30,000. Transamerica Financial Advisors LLC acquired a new stake in Astera Labs in the 2nd quarter valued at $35,000. Continuum Advisory LLC bought a new stake in Astera Labs in the second quarter valued at $37,000. Finally, Johnson Financial Group Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth about $43,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.
The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.
Further Reading
- Five stocks we like better than Astera Labs
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
